News

Filter

Four medicines recommended for approval by EMA/CHMP

Four medicines recommended for approval by EMA/CHMP

22-12-2013

Following regular monthly meeting of the European Medicines Agency’s Committee for Medicinal Products…

AlconAntibiotics and Infectious diseasesComtriqDermatologicalsEuropeGaldermaJanssen-CilagJohnson & JohnsonMirvasoNovartisOncologyOphthalmicsPharmaceuticalRegulationSirturoTMC Pharma Services

EMEA recommends Janssen-Cilag’s Regranex not be used in patients with any pre-existing cancer

19-02-2010

Following a review of the available data on a possible risk of cancer in patients using Regranex (becaplermin),…

BecaplerminDermatologicalsEuropeJanssen-CilagJohnson & JohnsonPharmaceuticalRegranexRegulation

COMPANY SPOTLIGHT

Menarini

Back to top